Zobrazeno 1 - 10
of 163
pro vyhledávání: '"James N. Atkins"'
Autor:
Nadine J. McCleary, Sui Zhang, Chao Ma, Fang-Shu Ou, Tiffany M. Bainter, Alan P. Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Bert H. O'Neil, Blase N. Polite, Howard S. Hochster, James N. Atkins, Richard M. Goldberg, Kimmie Ng, Robert J. Mayer, Charles D. Blanke, Eileen M. O'Reilly, Charles S. Fuchs, Jeffrey A. Meyerhardt
Publikováno v:
J Geriatr Oncol
BACKGROUND: Little is known about the interaction of comorbidities and age on survival outcomes in colorectal ancer (mCRC), nor how comorbidities impact treatment tolerance. METHODS: We utilized a cohort of 1,345 mCRC patients enrolled in CALGB/SWOG
Autor:
Norman Wolmark, V. Craig Jordan, Leslie G. Ford, Worta McCaskill-Stevens, Steven E. Reis, Patricia A. Ganz, Carolyn D. Runowicz, Joan James, Richard G. Margolese, André Robidoux, James L. Wade, Eduardo R. Pajon, Louis Fehrenbacher, Therese B. Bevers, James N. Atkins, Reena S. Cecchini, Walter M. Cronin, D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel
Perspectives on this Article from Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9f388966e431da8a9096898638207b
https://doi.org/10.1158/1940-6207.22523329.v1
https://doi.org/10.1158/1940-6207.22523329.v1
Autor:
Deanna L. Kroetz, Kouros Owzar, Alan P. Venook, Mark J. Ratain, Federico Innocenti, Howard L. McLeod, William Kevin Kelly, Susan Halabi, Hope S. Rugo, James N. Atkins, Heinz-Josef Lenz, Howard S. Hochster, Donna Niedzwiecki, Michiaki Kubo, Yukihide Momozawa, Paula N. Friedman, Fei Shen, Bryan P. Schneider, Bert H. O’Neil, Chen Jiang, Flora Mulkey, Megan Li
Purpose: Bevacizumab is a VEGF-specific angiogenesis inhibitor indicated as an adjunct to chemotherapy for the treatment of multiple cancers. Hypertension is commonly observed during bevacizumab treatment, and high-grade toxicity can limit therapy or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e99a814a31f502415951927ae4a4f7e
https://doi.org/10.1158/1078-0432.c.6525887
https://doi.org/10.1158/1078-0432.c.6525887
Autor:
Deanna L. Kroetz, Kouros Owzar, Alan P. Venook, Mark J. Ratain, Federico Innocenti, Howard L. McLeod, William Kevin Kelly, Susan Halabi, Hope S. Rugo, James N. Atkins, Heinz-Josef Lenz, Howard S. Hochster, Donna Niedzwiecki, Michiaki Kubo, Yukihide Momozawa, Paula N. Friedman, Fei Shen, Bryan P. Schneider, Bert H. O’Neil, Chen Jiang, Flora Mulkey, Megan Li
Supplemental Methods, Tables and Figures Table S1. Analyzed candidate genes Table S2. Gene sets and pathways used for candidate gene selection Table S3. Quality of sequencing reads per sample Table S4. Post-QC quality per sample Table S5. Replication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7f6e43ffa601f9d5a68422bda7d13a
https://doi.org/10.1158/1078-0432.22464992
https://doi.org/10.1158/1078-0432.22464992
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort
Autor:
Aidnag Z. Diaz, James N Atkins, Lydia Komarnicky, Jonathan P.S. Knisely, Steven P. Howard, David L. Rimm, Maria Vassilakopoulou, Jason A. Hanna, Veronique Neumeister, Edward Melian, Christopher J. Schultz, Corey J. Langer, Peixin Zhang, Michael D. Prados, Minhee Won, Adam P. Dicker, Luis Souhami, Walter J. Curran
Publikováno v:
Oncology
Purpose: Glioblastoma, the most common malignant brain tumor, was associated with a median survival of Methods and Materials: A TMA composed of archived glioblastoma tumors from patients treated with surgery, radiation, and non-TMZ chemotherapy, wa
Autor:
Kimmie Ng, Charles D. Blanke, Robert J. Mayer, Eileen M. O'Reilly, Brendan J. Guercio, Kaori Sato, Jeffrey A. Meyerhardt, Bert H. O'Neil, Alan P. Venook, Fang-Shu Ou, Howard S. Hochster, Sui Zhang, James N. Atkins, Blase N. Polite, Richard M. Goldberg, Erin L. Van Blarigan, Charles S. Fuchs, Donna Niedzwiecki, James Edward Shaw, Federico Innocenti, Heinz-Josef Lenz
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 37, iss 29
PURPOSE Regular physical activity is associated with reduced risk of recurrence and mortality in patients with nonmetastatic colorectal cancer. Its influence on patients with advanced/metastatic colorectal cancer (mCRC) has been largely unexplored. P
Autor:
Anthony J. Olszanski, Patrick M. Forde, Olivier Rixe, Yanyan Lou, Asha Nayak-Kapoor, David S. Hong, Vi K. Chiu, Floyd Fox, Margaret A. Marshall, Agron Collaku, Tomislav Dragovich, Rom Leidner, James N. Atkins
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(3)
Purpose: The aim of the study was to determine safety, antitumor activity, and pharmacodynamic profile of mogamulizumab, an anti-CCR4 monoclonal antibody targeting effector regulatory T cells (Treg) in combination with the checkpoint inhibitor nivolu
Autor:
Alan P. Venook, Sui Zhang, Erin L. Van Blarigan, Edward Giovannucci, Donna Niedzwiecki, Mingyang Song, Alexander Hantel, Fang-Shu Ou, Shuji Ogino, James N. Atkins, Leonard B. Saltz, Al B. Benson, Charles S. Fuchs, Robert J. Mayer, Jeffrey A. Meyerhardt
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 27, iss 10
Background: Higher intake of long-chain ω-3 polyunsaturated fatty acids and nuts, rich plant sources of unsaturated fats, after colon cancer diagnosis are associated with improved survival. It is not known whether the amount or the distribution of o
Autor:
Kouros Owzar, Bryan P. Schneider, Donna Niedzwiecki, Yukihide Momozawa, Megan Li, Heinz-Josef Lenz, Chen Jiang, Michiaki Kubo, Flora Mulkey, Deanna L. Kroetz, Paula N. Friedman, Howard L. McLeod, Fei Shen, Alan P. Venook, William Kevin Kelly, Susan Halabi, Bert H. O'Neil, Howard S. Hochster, Federico Innocenti, Mark J. Ratain, Hope S. Rugo, James N. Atkins
Publikováno v:
Clinical Cancer Research. 24:4734-4744
Purpose: Bevacizumab is a VEGF-specific angiogenesis inhibitor indicated as an adjunct to chemotherapy for the treatment of multiple cancers. Hypertension is commonly observed during bevacizumab treatment, and high-grade toxicity can limit therapy or
Autor:
Edward Giovannucci, Eric G. Wolfe, Federico Innocenti, Fang-Shu Ou, Chloe E. Atreya, Charles D. Blanke, James E. Shaw, Kimmie Ng, Charles S. Fuchs, Sui Zhang, Richard M. Goldberg, Alan Venlo, Jeffrey A. Meyerhardt, Robert J. Mayer, Blase N. Polite, Erin L. Van Blarigan, James N. Atkins, Bert H. O'Neil, Eileen M. O'Reilly, Howard S. Hochster, Donna Niedzwiecki, Heinz-Josef Lenz, Katherine Van Loon
Publikováno v:
JAMA Network Open
Key Points Question Is diet quality at initiation of first-line treatment for metastatic colorectal cancer associated with overall survival? Findings In this cohort study including 1284 people with metastatic colorectal cancer enrolled between 2005 a